RNA Based Vaccine Market Investment Trends and Strategic Partnerships
Investment activity in the RNA based vaccine market has reached unprecedented levels as venture capital firms, pharmaceutical giants, and government agencies commit substantial resources to platform development and commercialization. The market has attracted over USD 28 billion in cumulative investment since 2020, with Moderna and BioNTech alone raising combined revenues exceeding USD 18...
0 Σχόλια 0 Μοιράστηκε 4 Views 0 Προεπισκόπηση